RxDoctor Payments Data

Adam Perry, MD

Orthopaedic Surgery · Lafayette, LANPI 1477741155

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Zimmer Biomet at 45.1% of the total. 2024 is the largest year on record at $2,170, 2.1 times the $1,020 reported in 2020.

$6,736in general payments, 2019–2025

Across 50 payments — averaging $134.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$3K
  • ALON Medical Technology$2K
  • Arthrex$1K
  • Stryker$294
  • Bioventus LLC$19
  • Pfizer$17

What the payments were for

  • Travel & lodging$3,68855%
  • Food & beverage$1,84727%
  • Education$1,20018%

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet23$3,036
ALON Medical Technology7$2,286
Arthrex15$1,084
Stryker3$294
Bioventus LLC1$19
Pfizer1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,736 in reported general payments places this provider in the 60th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana →

Medicare billing

Part B allowed, 2024
$93,444
Medicare patients
210
Services billed
1,812

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl35$101
Meloxicam27$47

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Lafayette

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →